Monday, October 26, 2026 · Daily editionET --:--:--

Status not kept up to date

Clinical Study of Endovascular Interventional Surgical Instrument Control System and Related Consumables in Percutaneous Coronary Intervention

NCT05642286 · Shanghai Operation Robot Co., Ltd. · Updated 8 Dec 2022

What is being tested
ALLVAS® robotic-assisted PCI
For
Percutaneous Coronary Intervention; Coronary Heart Disease; Robotic Surgical Procedures
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 75 years. About 218 people. The full rules are on the registry page.
Where
Not stated
When
Starts or started 1 Dec 2022, ends 31 Dec 2024. Registered 8 Dec 2022.
Results
None posted yet.

In the researchers' words

The goal of this study is to evaluate the safety and effectiveness of endovascular interventional surgery instrument control system (ALLVAS®robot)and supporting consumables for coronary artery interventional surgery. Participants will will complete coronary intervention surgery with the assistance of robot system(ALLVAS®robot), and evaluate the effect of the use effect of robots and clinical treatment after surgery
ClinicalTrials.gov, NCT05642286